In vivo biotinylation tagging, based on a method in which a protein of interest is tagged with a peptide that is biotinylated in vivo by coexpression of Escherichia coli BirA biotin ligase, has been successfully used for the isolation of protein-protein and protein-DNA complexes in mammalian cells. We describe a modification of this methodology in which cells stably expressing the tagged gene of interest and the BirA gene can be selected by fluorescence-activated cell sorting (FACS). We recently implemented this approach to isolate and characterize proteins associated with TLX1, a homeodomain transcription factor with leukemogenic function. The modified technique utilizes two components: a lentiviral vector coexpressing the gene of interest containing a biotinylation tag on a bicistronic transcript together with a downstream yellow fluorescent protein (YFP) gene; and a second lentiviral vector encoding a fusion protein composed of bacterial BirA linked to the green fluorescent protein (GFP). This FACS-based binary in vivo biotinylation tagging system allows precise control over the levels of BirA-mediated biotinylation as well as the expression of the gene of interest, which is especially important if high-level expression negatively impacts cell growth or viability.
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Teresa S. Hawley and Robert G. Hawley (eds.), Flow Cytometry Protocols, Methods in Molecular Biology, vol. 699, DOI 10.1007/978-1-61737-950-5_21, © Springer Science+Business Media, LLC 2011 during purification (5) . The biotinylation tagging method described here has been successfully used for the single-step purification (6) of a number of transcription factor complexes in nuclear extracts of mammalian cells (4, (7) (8) (9) (10) (11) (12) .
In the initial version of the method (4), expression cassettes encoding the tagged protein of interest and BirA were subcloned into separate plasmids that also carried a selectable drug resistance gene, the neomycin phosphotransferase gene and the puromycin N-acetyltransferase gene, respectively. Typically, target cells would be transfected with the BirA plasmid by physical methods, such as electroporation, stable clones obtained by the selection of puromycin resistance, and then screened for BirA expression by Northern or Western blot analysis. An appropriate BirAexpressing clone would then be transfected with the vector encoding the tagged protein of interest and stable cells expressing the tagged protein biotinylated by BirA obtained by selection for cells that were resistant to the neomycin analog geneticin as well as to puromycin. A drawback of this experimental design is that the optimal concentration of drugs used for the selection depends on the cell line and needs to be determined a priori. Moreover, the selection for drug resistance of the transfected plasmids does not necessarily ensure the coexpression of BirA or the tagged gene of interest.
Hoang and colleagues reported a modification of this methodology in which the tagged gene of interest was coexpressed from a lentiviral vector on a bicistronic transcript that also contained the BirA gene (9) . In addition, the BirA gene was expressed as a fusion protein with the green fluorescent protein (BirA-GFP), allowing stably transduced cells coexpressing the tagged gene of interest and BirA to be isolated by FACS. As described below, we have further modified the FACS-based strategy of Hoang and colleagues. The expression system we have developed consists of two components: a lentiviral vector coexpressing the gene of interest containing a biotinylation tag together with a downstream yellow fluorescent protein (YFP) gene via an encephalomyocarditis virus internal ribosome entry site (IRES); and a second lentiviral vector expressing GFP-BirA (12) .
Our work is focused on TLX1 (T-cell leukemia homeobox 1, previously known as HOX11 or TCL3), an evolutionarily conserved member of the dispersed NKL (NK-Like or NK-Linked) subclass of homeobox genes (13, 14) . The murine ortholog of human TLX1 is essential for splenogenesis and required for the development of certain neurons (15, 16) . Although TLX1 is not expressed in the hematopoietic system, its inappropriate activation is a recurrent event in human T cell acute lymphoblastic leukemia (T-ALL) (17) . The manner in which deregulated TLX1 expression induces neoplastic conversion remains to be fully elucidated (18, 19) . Several lines of evidence indicate that TLX1 functions as a transcriptional regulator that can either activate or repress gene expression via direct or indirect modes of action (20) (21) (22) (23) (24) (25) (26) (27) (28) . In this regard, TLX1 has been reported to form proteinprotein interactions with other transcription factors as well as with a number of transcriptional coregulators and chromatin-modifying enzymes. Among the molecules that have been identified are: CTF1, a ubiquitous transcription factor that associates with TFIIB and the basal transcription machinery (29) ; MEIS and PBX members of the TALE (three amino acid loop extension) superclass of homeodomain proteins (30, 31) ; the acetyltransferase coactivator CREB-binding protein (26) ; the serine/threonine phosphatases PP1 and PP2A (25, 32) ; and the eukaryotic initiation factor 4E (eIF4E) (33) .
We recently implemented the in vivo biotinylation tagging approach to isolate and characterize the various TLX1 protein complexes in T-ALL cells (12) . Our initial attempts to coexpress biotinylation-tagged TLX1 and GFP-BirA from a bicistronic lentiviral vector were unsuccessful because the cells did not tolerate high levels of TLX1. Since BirA was expressed on the same transcript, it was selected against. As a result, much higher expression levels of BirA were achieved with the empty GFP-BirA vector, making it difficult to obtain similar levels of endogenous biotinylated proteins for comparisons between the experimental and control samples. To circumvent these problems, we designed a two-component expression system using the simian immunodeficiency virus (SIV) lentiviral vector backbone pCL20cSLFR MSCV-GFP (34) . In pCL20cSLFR MSCV-GFP, which was constructed from the nonpathogenic SIV mac1A11 isolate, the GFP gene is expressed from an internal promoter derived from the long terminal repeat (LTR) of the murine stem cell virus (MSCV), which is highly active in most mammalian cell types (35) . A biotinylation tagging vector expressing a COOH-terminal tagged TLX1 (TLX1 bio ) under the control of the MSCV LTR was created by inserting the TLX1 coding region in frame upstream of the coding sequences for the BirA target peptide linked to an IRES-YFP cassette, generating pCL20cSLFR MSCV-TLX1 bio -IRES-YFP (component 1). A BirA expression vector was similarly constructed by replacing the GFP gene of pCL20cSLFR MSCV-GFP with GFP-BirA, generating pCL20cSLFR MSCV-GFP-BirA (component 2) (Fig. 1a) .
In pilot studies, SupT1 cells, which are negative for TLX1 expression but which are arrested at the same stage of T-cell differentiation as TLX1 + T-ALL cells, were transduced with recombinant CL20cSLFR MSCV-TLX1 bio -IRES-YFP lentiviral vector particles and/or recombinant CL20cSLFR MSCV-GFP-BirA lentiviral vector particles and stable cell lines obtained by sorting for YFP and/or GFP fluorescence (Fig. 1b) . SupT1 cells expressing GFP-BirA alone served as control for the binding of any biotinylated endogenous proteins to the streptavidin beads. Using single-step affinity capture on streptavidin beads, followed by matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry, we identified the Groucho/transducin-like Enhancer of split (Gro/TLE) family member TLE1 as an in vivo binding partner of TLX1 (12) (Fig. 2a) . Gro/TLE proteins are regulated by multiple signaling cascades and serve as corepressors for different families of transcription factors (36, 37) . The transcription factors that interact with Gro/TLE corepressors contain short peptide sequences related to either WRPW or to FXIXXIL (where X is any amino acid), the latter referred to as the Engrailed homology 1 (Eh1) motif, a repression domain first identified in the Drosophila Engrailed homeodomain protein (38) . We demonstrated that TLX1 interacts with TLE1 in vitro and in vivo through a seven amino acid sequence encompassing amino acids 19-25 (FGIDQIL) that exhibits similarity to an Eh1 motif (Fig. 2b) . Moreover, we found that this motif was required for optimal regulation of expression of two TLX1 target genes, Aldh1a1 and Fhl1 (21, 22, 27) . As shown in Fig. 2a , a previously reported in vitro TLX1 interacting protein, eIF4E (33) , is also efficiently precipitated by streptavidin affinity capture of in vivo TLX1 bio protein complexes. Thus, we believe that our adaptation of the FACS-based in vivo biotinylation tagging system provides a powerful tool for the characterization of transcription factor and other protein-protein complexes in mammalian cells. 
SIV lentiviral vectors: pCL20cSLFR MSCV-TLX1
bio -IRES-YFP expressing the TLX1 homeodomain transcription factor containing a COOH-terminal biotinylation peptide tag linked to a downstream YFP reporter on a bicistronic transcript (12); pCL20cSLFR MSCV-GFP-BirA expressing a fusion protein consisting of a GFP reporter and the bacterial BirA biotin ligase (GFP-BirA) (12) . The pCL20cSLFR MSCV-IRES-YFP and pCL20cSLFR MSCV-GFP-BirA plasmids can be obtained from the authors upon request. , and anti-eIF4E (P-2) (all from Santa Cruz Biotechnology, Inc., Santa Cruz, CA). TLE1 was initially identified as a TLX1-interacting protein by mass spectrometry (12) . Mass spectrometry analysis was performed using a Kratos Axima CFR/Plus instrument equipped with Kompact software (Shimadzu Biotech, Columbia, MD) in reflectron mode. (b) Schematic diagram of TLX1 indicating: a seven amino acid sequence (FGIDQIL) encompassing amino acids 19-25 exhibiting similarity to an Engrailed homology 1 (Eh1) motif (FXIXXIL, where X is any amino acid) that mediates interactions involving Gro/TLE corepressors (38); a seven amino acid sequence (YGLGCLV) encompassing amino acids 45-51 representative of a consensus eukaryotic initiation factor 4E (eIF4E)-binding motif (YXXXXLF, where X is any amino acid and F is a hydrophobic residue) (33) ; and, the homeodomain (HD), which is deleted in the version of TLX1 bio used in these experiments (12).
Materials

Biotinylation Tagging Vectors
3. Restriction and modifying enzymes for PCR amplification and subcloning of genes of interest. Collect the culture medium containing vector particles 24-48 h after medium change. Centrifuge at 2,000 × g for 10 min to remove cellular debris and filter through a 0.45 mm pore-size filter (depending on the volume, use a 150-mL filter unit or a small filter unit attached to a 5-mL syringe). Use directly for transductions or aliquot and store at −80°C (see Note 7). Several procedures have been developed to concentrate lentiviral vector particles (43) . The choice of concentration protocol depends on the envelope selected to pseudotype the particle and the quantities of particles to be produced. The stability of the VSV-G envelope protein allows the generation of high-titer lentiviral vector particles by ultracentrifugation, as described here.
1. Ultracentrifuge the vector particles at 50,000 × g and 4°C for 90 min.
2. Discard supernatant. Using gentle pipetting, resuspend the pellet in ~100 mL of medium appropriate for the downstream application. To facilitate complete resuspension, vortex gently overnight at 4°C (see Note 8).
3. To remove cellular debris, centrifuge concentrated vector particles at 10,000 × g and 4°C for 5 min in a microcentrifuge. Collect the supernatant containing the vector particles, aliquot and freeze at −80°C (see Note 9).
The HT1080 human fibrosarcoma cell line can be used to determine the titer of the lentiviral vector particles.
1. Propagate HT1080 cells in HT1080 cell culture medium at 37°C in a humidified atmosphere with 5% CO 2 .
Collection and Concentration of Vector Particles
Titration of Vector Particles
2. 4-6 h prior to titrating the vector particles, plate 2. −4 for concentrated vector particles) using cell culture medium, in a final volume of 1 mL per dilution. Add 1 mL of polybrene stock solution to each dilution. Remove the medium from the cells and add 1 mL of each dilution to each well. Incubate at 37°C for 4 h.
Remove the vector particles after the 4-h transduction and
replace with 2 mL of fresh cell culture medium. Return to the CO 2 incubator and incubate at 37°C. The following protocol is used to transduce suspension cell lines with the recombinant biotinylation tagging lentiviral vectors. For adherent cells, the protocol described in Subheading 3.2.3 for titration of vector particles is used.
1. Propagate cells (e.g., SupT1) in suspension cell culture medium at 37°C in a humidified atmosphere with 5% CO 2 .
2. Prepare an appropriate dilution of vector particles in 1 mL of cell culture medium containing 1 mL of polybrene stock solution. Resuspend 1-2 × 10 5 cells in the diluted vector particles in a 14-mL conical polystyrene centrifuge tube. 
Generation of Cells Stably Expressing BiotinTagged Proteins
The protocol described below is a variation of the Dignam procedure for the preparation of nuclear extracts for human tissue culture cells (45) that has been modified for T-ALL cell lines (e.g., SupT1). The standard procedure is based on a starting cell number of 2 × 10 8 cells and can be adjusted to accommodate 2 × 10 9 cells by increasing the buffer volumes at steps 2 and 3 by a factor of 4. All solutions are kept on ice; prior to cell harvesting, freshly thawed PMSF and DTT, and freshly prepared protease and phosphatase inhibitors are added to the prechilled buffers.
Centrifugations are performed at 4°C.
1. Harvest the cells by centrifuging at 600 × g for 10 min.
2. Wash once in 10 mL of PBS and centrifuge at 600 × g for 10 min.
3. Wash once in 10 mL of hypotonic wash buffer and centrifuge at 600 × g for 5 min.
4. Remove supernatant immediately and discard; resuspend the pellet in 3 mL of hypotonic wash buffer.
5. Subject the cells to hypotonic shock by incubating for 30 min.
6. Check the efficiency of cell lysis under a microscope by staining an aliquot with trypan blue.
7. Centrifuge homogenate at 3,300 × g for 15 min.
8. Remove supernatant (mostly composed of cytosolic and loosely-associated nuclear proteins) and adjust salt concentration by adding an equal volume of NP40 NE buffer. Freeze sample at −80°C or keep on ice until streptavidin affinity precipitation (see Subheading 3.5).
9. Resuspend the pellet in 3 mL of NP40 NE buffer.
10. Incubate for 30 min on ice to extract nuclear proteins; during the incubation period, shear DNA either by mild sonication (e.g., for 20 s using a Branson sonifier 250 set at constant duty and microtip output control limited to 3) or by passing the material through a 25-gauge needle.
11. Freeze sample at −80°C or keep on ice until streptavidin affinity precipitation (see Subheading 3.5).
Streptavidin affinity precipitation is performed essentially as described (6) (see Note 12).
1. Wash 120 mL of streptavidin sepharose beads (for two samples) with 1 mL of HENG buffer. Centrifuge at 10,000 × g for 20 s. Resuspend the beads in 500 mL of HENG buffer containing 200 mg/mL of chicken albumin and incubate on a rotating platform for 1 h at room temperature. Centrifuge and resuspend the beads in 65 mL of HENG buffer.
Cell Fractionation
Streptavidin Affinity Precipitation and Mass Spectrometry Analysis
2. Centrifuge the samples at 25,000 × g for 30 min. To decrease nonspecific binding, transfer supernatants to new tubes even if there is no visible insoluble material.
3. Add 30 mL of streptavidin bead suspension per sample and incubate on a rotating platform for 1 h at 4°C.
4. Wash the sample twice by resuspending in 1 mL of NP40 T buffer and centrifuging at 10,000 × g for 20 s.
5. Wash the sample three times by resuspending in 1 mL of NP40 T buffer, incubating on a rotating platform at room temperature for 5 min, and centrifuging at 10,000 × g for 20 s.
6. Resuspend the material in 2× loading buffer and fractionate by SDS-PAGE.
7. Stain gel with colloidal blue. Excise discretely stained bands that are evident only in the presence of biotinylated protein of interest.
8. Subject each band to in-gel tryptic digestion. Desalt and concentrate resultant peptides through a ZipTip, and elute in 5 mL of elution buffer.
9. Load 1 mL of peptides and 1 mL of a-cyano-CHCA matrix onto a target plate.
10. Conduct peptide mass fingerprinting using MALDI-TOF mass spectrometry. Perform protein database searches using Mascot software (www.matrixscience.com).
11. Confirm the identity of interacting proteins revealed by mass spectrometry using Western blot analysis.
1. More recently, we have constructed an NH 2 -terminal biotintagged TLX1 ( bio TLX1) modeled after the bio Nanog homeodomain protein and other biotin-tagged transcription factors described by Orkin and colleagues (46, 47) , which is based on the 15 amino acid AviTag™ sequence (GLNDIFEAQKIEWHE) that is very efficiently biotinylated in vivo by BirA (Avidity, LLC, Aurora, CO; www.avidity.com). 4. Common recombinant DNA techniques are used for plasmid DNA preparations, restriction enzyme digestions, PCR amplifications, and subclonings. Detailed protocols for each technique can be obtained from commercial sources, as well as from various standard molecular biology manuals. Accordingly, these techniques have not been described here.
5. The pCL20cSLFR MSCV-GFP SIV-based vector system is modeled after "third generation" lentiviral vector systems that have incorporated features to enhance safety and improve the efficiency of vector particle production (50) . Specifically, several viral accessory proteins have been eliminated from the pCAG-SIVgprre gag-pol packaging construct, and the LTRs have been modified to contain the human CMV enhancerpromoter and to eliminate Tat dependence during vector production (5¢ LTR) and to be self-inactivating (3¢ LTR) upon integration. Because both the expression of the pCL20cSLFR MSCV-GFP SIV lentiviral vector backbone as well as the gag and pol genes encoded by the pCAG-SIVgprre packaging construct are dependent on transcomplementation by the Rev protein, use of this system requires cotransfection with a rev expression construct (e.g., pCAG4-RTR-SIV).
6. Vector titer depends on the vector backbone design, the size and nature of inserted sequences as well as the efficiency of transfection. To achieve optimal transfection efficiency, use an exponentially growing culture (50-70% confluent) of 293T cells for transfection and make sure that the cells form a uniform monolayer upon plating. Transfection efficiency is also affected by the quality of the plasmid DNA used. Commercially available plasmid DNA purification kits usually yield highly purified endotoxin-free supercoiled plasmid DNA (traditionally obtained by purifying on two separate cesium chloride gradients). Sterilize the plasmid DNA by ethanol precipitation, resuspend the air-dried pellet in sterile, deionized water, and determine its concentration and quality by spectrophotometric analysis and gel electrophoresis. Pay special attention to the pH of the 2× HBS solution, which should be between 7.05 and 7.12. Upon addition of the transfection mixture to the cells, a fine precipitate should develop within a few minutes.
7. pH and temperature fluctuations as well as freeze-and-thaw frequency could have an impact on the stability of vector particles, and hence, vector titer (51). Minimize pH changes by adding HEPES at a final concentration of 10 mM to buffer the cell culture medium. Once collected, vector particles should be kept on ice at all times. For future use, they should be stored in aliquots at −80°C. Avoid repeated freezing and thawing.
8. Small (~2 to 5-mm-diameter) pellets should be visible after concentration by centrifugation. Expect a 50-75% recovery following vector concentration.
9. The vector particle preparation can be further purified if necessary by centrifuging through a sucrose cushion (52).
10. When reporter proteins are evaluated by flow cytometry, it is advantageous to wait at least 5 days before analyzing the transduced cells. This minimizes the contribution of false positive signals due to pseudotransduction, which is the direct transfer of reporter protein (adhered to vector particles or incorporated into vector particles) to the target cells; this is particularly problematic for VSV-G glycoprotein-pseudotyped vectors (53, 54) . Note that it has also been shown that transgenes can be efficiently transiently expressed from unintegrated lentiviral vectors during this timeframe (10-14 days) (55).
11. When the target cells already express the protein of interest, sort YFP/GFP-positive cells that express a subendogenous level of the biotin-tagged protein so as to avoid perturbing any existing protein-protein network interactions. To further minimize competition between endogenous and biotintagged proteins under these circumstances, we have recently adapted the shRNA-expressing pLKO.1-puro lentiviral vector (56) , by substituting the puromycin N-acetyltransferase gene with the cyan fluorescent protein (CFP) gene so that simultaneous knockdown of endogenous transcripts can be achieved by sorting CFP-positive cells.
12. While single-step purification to generate protein complexes sufficiently clean to be analyzed by mass spectrometry is a strength of the in vivo biotinylation approach (6), it might be advantageous to perform tandem-affinity purifications in some experiments. Elegant studies carried out by Orkin and colleagues in murine embryonic stem cells to elaborate the transcriptional interaction network involving nine transcription factors, including the Nanog homeoprotein, have validated and demonstrated the utility of in vivo biotinylation of tagged proteins and streptavidin affinity capture to identify downstream targets on a global scale by ChIP-on-chip (46, 47) . In those studies, both single-step capture on streptavidin beads as well as tandem purification with anti-Flag immunoprecipitation followed by capture with streptavidin were carried out. For example, candidate Nanog-interacting proteins fell into three groups: the first group included proteins present in at least two of three independent one-step purifications and tandem purification; the second group included proteins that may be part of unstable or transient complexes that dissociate during tandem purification; and the third group contained proteins that were "masked" in onestep purifications but were recovered in the tandem procedure (46) . For this reason, we have also included NH 2 -terminal Flag tags on our recombinant proteins (12, 23, 26) , which can be used for this purpose.
